Standardization of 123I-metaiodobenzylguanidine cardiac neurotropic scintigraphy and single-photon emission tomography
Current review describes the prerequisites for clinical application of nuclear imaging with metaiodobenzylguanidine for cardiac sympathetic activity assessment. As the method developed, various quantitative parameters were proposed to evaluate its results. Some of them are still calculated and inter...
Main Authors: | A. A. Ansheles, V. B. Sergienko |
---|---|
Format: | Article |
Language: | English |
Published: |
Luchevaya Diagnostika, LLC
2016-07-01
|
Series: | Вестник рентгенологии и радиологии |
Subjects: | |
Online Access: | https://www.russianradiology.ru/jour/article/view/142 |
Similar Items
-
Uptake index of 123I-metaiodobenzylguanidine myocardial scintigraphy for diagnosing Lewy body disease
by: Yoshito Kamiya, et al.
Published: (2017-01-01) -
Establishment of Quality Standard for Metaiodobenzylguanidine as Radiopharmaceutical Precursor
by: CHEN Mengyi;DONG Ruilin;XING Yu;ZHOU Jiajun;QIU Shanshan;SUN Mingyue;WANG Xiaoming;WU Fuhai;HU Ji
Published: (2023-02-01) -
The Prognostic Value of the Results of <sup>123</sup>I-metaiodobenzylguanidine Myocardial Scintigraphy in the Examination of Patients with Atrial Fibrillation Referred for Its Interventional Treatment
by: Yu. V. Varlamova, et al.
Published: (2019-11-01) -
Cardiac I-metaiodobenzylguanidine Scintigraphy in a Patient with Familial Parkinsonism with Gene Mutation
by: Young-Do Kim, et al.
Published: (2010-10-01) -
Development of an 123I-metaiodobenzylguanidine Myocardial Three-Dimensional Quantification Method for the Diagnosis of Lewy Body Disease
by: Yoshito Kamiya, et al.
Published: (2018-06-01)